{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:41:12Z","timestamp":1779180072395,"version":"3.51.4"},"reference-count":48,"publisher":"SAGE Publications","issue":"1_suppl","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicol Pathol"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:p>The performance of the p53 +\/- transgenic (knockout) mouse model was evaluated through review of the data from 31 short-term carcinogenicity studies with 21 compounds tested as part of the International Life Sciences Institute's (ILSI) Alternatives to Carcinogenicity Testing (ACT) project, together with data from other studies which used comparable protocols. As expected based on the hypothesis for the model, a significant number (12\/16 or 75%) of the genotoxic human and\/or rodent carcinogens tested were positive and the positive control, p-cresidine, gave reproducible responses across laboratories (18\/19 studies positive in bladder). An immunosuppressive human carcinogen, cyclosporin A, was positive for lymphomas but produced a similar response in wild type mice. Two hormones that are human tumorigens, diethylstilbestrol and 17\u03b2-estradiol, gave positive and equivocal results, respectively, in the pituitary with p53-defi cient mice showing a greater incidence of proliferative lesions than wild type. None of the 22 nongenotoxic rodent carcinogens that have been tested produced a positive response but 2 compounds in this category, chloroform and diethylhexylphthalate, were judged equivocal based on effects in liver and kidney respectively. Four genotoxic noncarcinogens and 6 nongenotoxic, noncarcinogens were also negative. In total (excluding compounds with equivocal results), 42 of 48 compounds or 88% gave results that were concordant with expectations. The technical lessons learned from the ILSI ACT-sponsored testing in the p53+\/- model are discussed.<\/jats:p>","DOI":"10.1080\/019262301753178465","type":"journal-article","created":{"date-parts":[[2003,1,29]],"date-time":"2003-01-29T23:23:13Z","timestamp":1043882593000},"page":"30-50","source":"Crossref","is-referenced-by-count":92,"title":["p53 +\/- Hemizygous Knockout Mouse: Overview of Available Data"],"prefix":"10.1177","volume":"29","author":[{"given":"Richard D.","family":"Storer","sequence":"first","affiliation":[{"name":"Merck & Co Inc, West Point, Pennsylvania 19486, richardstorer@merck.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"French","sequence":"additional","affiliation":[{"name":"National Institute of Environmental Health Sciences,\rResearch Triangle Park, North Carolina 27709"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Haseman","sequence":"additional","affiliation":[{"name":"National Institute of Environmental Health Sciences,\rResearch Triangle Park, North Carolina 27709"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Hajian","sequence":"additional","affiliation":[{"name":"Schering Plough Research Institute, Kenilworth, New\rJersey 07083"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund K.","family":"Legrand","sequence":"additional","affiliation":[{"name":"RW Johnson Pharmaceutical Research Institute, Raritan\rNew Jersey 08869"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald G.","family":"Long","sequence":"additional","affiliation":[{"name":"Eli Lilly & Co, Greenfield, Indiana 46140"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori A.","family":"Mixson","sequence":"additional","affiliation":[{"name":"Merck & Co Inc, West Point, Pennsylvania 19486"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Ochoa","sequence":"additional","affiliation":[{"name":"Pfizer, Inc, Groton, Connecticut 06340"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Sagartz","sequence":"additional","affiliation":[{"name":"Monsanto, St. Louis, MO 63141"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.","family":"Soper","sequence":"additional","affiliation":[{"name":"Merck & Co Inc, West Point, Pennsylvania 19486"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2001,1,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(95)00196-4"},{"key":"atypb2","volume-title":"personal communication","year":"2000"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(99)00196-2"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1177\/019262339902700505"},{"key":"atypb5","unstructured":"Caldwell J, this volume."},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.0010861"},{"issue":"1","key":"atypb7","first-page":"71","volume":"106","year":"1998","journal-title":"Environ Health Perspect"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1006\/scbi.1996.0035"},{"key":"atypb9","first-page":"1","volume":"395","year":"1995","journal-title":"Prog Clin Biol Res"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1038\/356215a0"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1002\/mc.2940140105"},{"key":"atypb12","unstructured":"Donehower LA, this volume"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1177\/019262339702500601"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600401"},{"key":"atypb15","unstructured":"French, JE, this volume"},{"key":"atypb16","volume-title":"personal communication (glycidol, methylphenidate chloroprene)","year":"2000"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600404"},{"issue":"1","key":"atypb18","first-page":"A1202","volume":"48","year":"1999","journal-title":"Toxicol Sci"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1177\/019262330002800320"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1038\/ng1193-225"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1038\/ng0395-305"},{"key":"atypb22","first-page":"8983","volume":"63","year":"1998","journal-title":"Fed Reg"},{"key":"atypb23","volume-title":"personal communication","year":"1998"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1002\/mc.2940090309"},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202789"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1002\/mc.2940120304"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90461-X"},{"key":"atypb28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0994-66","volume":"8","year":"1994","journal-title":"Nat Genet"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600406"},{"issue":"1","key":"atypb30","first-page":"A969","volume":"60","year":"2001","journal-title":"Toxicol"},{"key":"atypb31","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.5.1039"},{"key":"atypb32","volume-title":"Workshop on the Evaluation of Alternative Methods for Carcinogenicity Testing: Poster #19"},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(98)00377-2"},{"issue":"17","key":"atypb34","first-page":"3806","volume":"58","year":"1998","journal-title":"Cancer Res"},{"key":"atypb35","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(99)00036-1"},{"key":"atypb36","unstructured":"Popp J, this volume."},{"key":"atypb37","volume-title":"personal communication","year":"2000"},{"key":"atypb38","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600402"},{"key":"atypb39","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600405"},{"key":"atypb40","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/53.2.213"},{"issue":"5","key":"atypb41","first-page":"513","volume":"27","year":"1999","journal-title":"ToxicolPathol"},{"key":"atypb42","first-page":"557","volume":"112","year":"2000","journal-title":"Toxicol Lett"},{"key":"atypb43","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.95103942"},{"key":"atypb44","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1110(96)90016-0"},{"issue":"2","key":"atypb45","first-page":"473","volume":"106","year":"1998","journal-title":"Environ Health Perspect"},{"issue":"1","key":"atypb46","first-page":"A1326","volume":"60","year":"2001","journal-title":"Toxicologist"},{"key":"atypb47","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.16.4657"},{"key":"atypb48","unstructured":"van Kreijl CF, this volume."}],"container-title":["Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/019262301753178465","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/019262301753178465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:26:22Z","timestamp":1777620382000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/019262301753178465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":48,"journal-issue":{"issue":"1_suppl","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1080\/019262301753178465"],"URL":"https:\/\/doi.org\/10.1080\/019262301753178465","relation":{},"ISSN":["0192-6233","1533-1601"],"issn-type":[{"value":"0192-6233","type":"print"},{"value":"1533-1601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}